CBD-Intel has found an overlap in some of the brands stocked by both US chain stores and independent retailer. For the full analysis of chain stores compared with independent stores, see our US in-depth market report here.
Europe’s still asking questions about novel food submission
A year and eight months after Cibdol submitted its novel food application for EU authorisation of synthetically produced CBD, the Swiss company is still fielding questions from the European Food Safety Authority (ESFA)
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
